SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-002926
Filing Date
2019-09-13
Accepted
2019-09-13 17:16:08
Documents
59
Period of Report
2019-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pharmacyte_10q-073119.htm 10-Q 366570
2 CERTIFICATION pharmacyte_ex3101.htm EX-31.1 8671
3 CERTIFICATION pharmacyte_ex3102.htm EX-31.2 8651
4 CERTIFICATION pharmacyte_ex3201.htm EX-32.1 4305
5 CERTIFICATION pharmacyte_ex3202.htm EX-32.2 4347
  Complete submission text file 0001683168-19-002926.txt   2786535

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pmcb-20190731.xml EX-101.INS 504412
7 XBRL SCHEMA FILE pmcb-20190731.xsd EX-101.SCH 34984
8 XBRL CALCULATION FILE pmcb-20190731_cal.xml EX-101.CAL 39202
9 XBRL DEFINITION FILE pmcb-20190731_def.xml EX-101.DEF 144657
10 XBRL LABEL FILE pmcb-20190731_lab.xml EX-101.LAB 244156
11 XBRL PRESENTATION FILE pmcb-20190731_pre.xml EX-101.PRE 220195
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 191093221
SIC: 2836 Biological Products, (No Diagnostic Substances)